Tuberculosis in Antiretroviral Treatment Programs in Lower Income Countries: Availability and Use of Diagnostics and Screening

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Fenner, Lukas ^a,b,c   Ballif, Marie ^a   Graber, Claire ^a   Nhandu, Venerandah ^d   Dusingize, Jean Claude ^e   Cortes, Claudia P ^f   Carriquiry, Gabriela ^g   Anastos, Kathryn ^h   Garone, Daniela ⁱ   Jong, Eefje ^j   Gnokoro, Joachim Charles ^k   Sued, Omar ^l   Ajayi, Samuel ^m   Diero, Lameck ⁿ   Wools Kaloustian, Kara ^n,o   Kiertiburanakul, Sasisopin ^p   Castelnuovo, Barbara ^q   Lewden, Charlotte ^r   Durier, Nicolas ^s   Sterling, Timothy R ^t   Egger, Matthias ^a   more..

^a UNIVERSITY OF BERN   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^e Women's Equity in Access to Care and Treatment   (Rwanda)

^f UNIVERSITY OF CHILE   (Chile)

^g INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁱ MÉDECINS SANS FRONTIÈRES   (Switzerland)

^j UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^k CEPREF ART Program   (Côte d’Ivoire)

^l FUNDACIÓN HUÉSPED   (Argentina)

^m UNIVERSITY OF ABUJA   (Nigeria)

ⁿ ACADEMIC MODEL PROVIDING ACCESS TO HEALTHCARE AMPATH   (Kenya)

^o INDIANA UNIVERSITY   (United States)

^p MAHIDOL UNIVERSITY   (Thailand)

^q Research Department   (Uganda)

^r UNIVERSITÉ DE BORDEAUX   (France)

^s TREAT Asia   (Thailand)

^t VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID;

ADULT; AFRICA; ARTICLE; ASIA; BACTERIUM CULTURE; DIAGNOSTIC TEST; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SCREENING TEST; SOUTH AND CENTRAL AMERICA; SPUTUM CYTODIAGNOSIS; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; AFRICA SOUTH OF THE SAHARA; ANTI-RETROVIRAL AGENTS; ASIA; FEMALE; GEOGRAPHY; HUMANS; LATIN AMERICA; MALE; QUESTIONNAIRES; TUBERCULOSIS;

EID: 84885788916     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077697     Document Type: Article

References (29)

1. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R, (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22: 1897-1908.
2. Brinkhof MW, Egger M, Boulle A, May M, Hosseinipour M, et al. (2007) Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. Clin Infect Dis 45: 1518-1521.
3. Lawn SD, Wilkinson RJ, Lipman MC, Wood R, (2008) Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med 177: 680-685.
4. Koenig SP, Riviere C, Leger P, Jospeh P, Severe P, et al. (2009) High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy. Clin Infect Dis 48: 829-831.
5. Davies MA, Meintjes G, (2009) Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs. Clin Infect Dis 49: 973-975.
6. Moh R, Danel C, Messou E, Ouassa T, Gabillard D, et al. (2007) Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa. AIDS 21: 2483-2491.
7. Meintjes G, Lawn SD, Scano F, Maartens G, French MA, et al. (2008) Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 8: 516-523.
8. Muller M, Wandel S, Colebunders R, Attia S, Furrer H, et al. (2010) Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 10: 251-261.
9. Badri M, Wilson D, Wood R, (2002) Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 359: 2059-2064.
10. Edmonds A, Lusiama J, Napravnik S, Kitetele F, Van RA et al. (2009) Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children. Int J Epidemiol.
11. Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, et al. (2012) Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med 9: e1001270.
12. Aït-Khaled N, Alarcon E, Bissell K, Boillot F, Caminero JA, et al. (2009) Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues. Int J Tuberc Lung Dis 13: 927-935.
13. Corbett EL, Marston B, Churchyard GJ, De Cock KM, (2006) Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 367: 926-937.
14. Lönnroth K, Raviglione M, (2008) Global epidemiology of tuberculosis: prospect for control. Sem Respir Crit Care Med 29: 481-491.
15. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, et al. (2010) Timing of initiation of antiretroviral drugs during tuberculosis therapy. The New England Journal of Medicine 362: 697-706.
16. Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, et al. (2011) Earlier versus later start of antiretroviral therapy in HIV-Infected adults with tuberculosis. New England Journal of Medicine 365: 1471-1481.
17. Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, et al. (2011) Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. New England Journal of Medicine 365: 1482-1491.
18. Fenner L, Forster M, Boulle A, Phiri S, Braitstein P, et al. (2011) Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. Int J Tuberc Lung Dis 15: 620-627.
19. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, et al. (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377: 1495-1505.
20. Nicol MP, Workman L, Isaacs W, Munro J, Black F, et al. (2011) Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 11: 819-824.
21. Egger M, Ekouevi DK, Williams C, Lyamuya RE, Mukumbi H, et al. (2012) Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa. Int J Epidemiol 41: 1256-1264.
22. Gange SJ, Kitahata MM, Saag MS, Bangsberg DR, Bosch RJ, et al. (2007) Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol 36: 294-301.
23. McGowan CC, Cahn P, Gotuzzo E, Padgett D, Pape JW, et al. (2007) Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol 36: 969-976.
24. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, et al. (2009) Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42: 377-381.
25. Lin HH, Dowdy D, Dye C, Murray M, Cohen T, (2012) The impact of new tuberculosis diagnostics on transmission: why context matters. Bull World Health Organ 90: 739-747A.
26. Lawn SD, Kerkhoff AD, Wood R, (2012) Location of Xpert(R) MTB/RIF in centralised laboratories in South Africa undermines potential impact. Int J Tuberc Lung Dis 16: 701.
27. World Health Organization (2011) Rapid implementation of the Xpert MTB/RIF diagnostic test. Technical and operational 'How to' practical considerations. World Health Organization Document WHO/HTM/TB/2011 2: 1-34.
28. Saito S, Howard AA, Reid MJ, Elul B, Scardigli A, et al. (2012) TB diagnostic capacity in sub-Saharan African HIV care settings. J Acquir Immune Defic Syndr 61: 216-220.
29. Zumla A, Abubakar I, Raviglione M, Hoelscher M, Ditiu L, et al. (2012) Drug-resistant tuberculosis-- current dilemmas, unanswered questions, challenges, and priority needs. Journal of Infectious Diseases 205: S228-S240.